Dr. Andrew Fishman presents on a consensus opinion panel regarding the management of newly diagnosed acoustic neuromas and the management of Neurofibromatosis type 2 (NF2).
Among the issues discussed included novel image guided applications for minimally invasive skull base approaches to tumors with the intent of preserving residual hearing.